CONTINENTAL STRATEGY, LLC

Lobbying for VIVEX BIOLOGICS · regenerative medicine company

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · Florida · $120,000.00 income · posted Oct 20, 2025

Lobbying activity 2

Health Issues

regenerative and innovative medical solutions

Science/Technology

regenerative and innovative medical solutions

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.